Tallinn, Estonia – Estonian veterinary pharmaceutical company Pharmapark OÜ has entered into a new strategic partnership with Dutch veterinary medicine brands Interchemie and Kepro. Together, the parties announced the creation of a new Dutch–Estonian joint venture under the name Interchemie. During the formation of the joint venture, Interchemie B.V. became the sole owner of Pharmapark OÜ and Pharmapark Production OÜ. Transition of production and workforceThe production and supply chain operations of Interchemie veterinary medicines in Estonia will be gradually transferred from Viimsi and Maardu to the Pharmapark factory in Tallinn. Pharmapark: One of Europe’s largest veterinary medicine factoriesIn 2024, Pharmapark inaugurated one of Europe’s largest and most modern veterinary medicine factories in Tallinn following a €50 million investment.